Medorrhinum homeopathic drug recalled for manufacturing process deviations
Washington Homeopathic Products recalled Medorrhinum liquid pellets nationwide due to deviations from manufacturing standards. The product was distributed in 49 glass amber bottles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Voluntary precautionary recall initiated by the manufacturer for current Good Manufacturing Practice deviations. The classification reflects a manufacturing process-level issue rather than a specific product defect or confirmed contamination.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Medorrhinum homeopathic remedy in potencies 12C, 30C, 200C, and 1M in liquid pellet form. The manufacturer initiated this voluntary recall on May 13, 2022, due to deviations from current Good Manufacturing Practice (cGMP) requirements.
The affected product was distributed nationwide in the United States. The recall covers 49 glass amber bottles with lot numbers 20211, 20543, and 22709.
Consumers who have affected product should stop using it and contact Washington Homeopathic Products, Inc. for guidance on returns or disposal. The recall was terminated on May 25, 2023.
The recalled product
- Product
- Medorrhinum, Potency:12C, 30C, 200C, 1M, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 20211
- 20543
- 22709
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27